NSF International acquires biotech & pharma lab company
Incorporated into the parent company’s Health Sciences Division, NSF Pharmalytica will operate mainly as a contract laboratory focusing on Good Laboratory Practice (GLP) and Good Manufacturing Practises (GMP).
Read more on Nutraingredients.com
Genzyme: Sanofi-Aventis to buy U.S. biotech company for $20.1B
Sanofi-Aventis is buying specialty drugmaker Genzyme for $20.1 billion, the latest example of a beleaguered pharmaceutical company snapping up high-priced biotech drugs to offset dwindling sales of older, simpler medications facing generic competition.
Read more on Inside Bay Area
Big demand for biotech company
Growing international demand for biotech company Canterbury Scientific’s products has prompted it to invest $1.2 million in new research and development facilities in Addington.
Read more on Stuff
This spot appeared on NBC Washington during the Jobs 4 You segment.
Fuld & Company – Competitive Intelligence and Strategic Gaming
Fuld & Company, the global leader in competitive intelligence, delivers customised research and analysis on markets, competitors, suppliers and customers.
Read more on Pharmaceutical Business Review
Interview With the CEO of Radient Pharmaceuticals Provides Perspective as Company Shares See Increased Volume and …
LOS ANGELES, CA–(Marketwire – December 27, 2010) – During the past few sessions, shares of Radient Pharmaceuticals ( NYSE Amex : RPC ) have seen increased volume and appreciation in anticipation of several key developments slated to occur in the short term. In an exclusive interview with BioMedReports, the leading news portal dedicated to delivering market intelligence to the biotech and …
Read more on Marketwire
UBC Innovation Is Advanced By The Centre For Drug Research And Development And Licensed By Global Healthcare Company
The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD) recently announced that Covidien, a leading global provider of healthcare products, has licensed an innovative drug-delivery platform technology invented by UBC researcher, Pieter Cullis
Read more on DrugDiscoveryOnline
Company Seeks Approval for GM ‘Non-Browning’ Apple
A B.C. biotech company is seeking approval for a GM apple it has developed that doesn’t turn brown once sliced.
Read more on The Epoch Times
World Leading Product Development Company Sagentia Announces Expansion of US Operations Through New Cambridge Office
Sagentia, an international technology and product development company based in Cambridge, U.K., and the Massachusetts Life Sciences Center announced today the recent opening of Sagentia’s new Cambridge, Massachusetts location.
Read more on Business Wire via Yahoo! Finance
2005 BioTech Counter Convention in Philadelphia. Discussion of the ethics of health care. ethics of doctors who prescribe medicine based off a pamphlet from a drug company representative.
Powered by Yahoo! Answers
